UPS Enhances Cryogenic Logistics with Monitoring, Intervention and Financial Risk Mitigation Solutions

US 11/03/14

Atlanta, GA

UPS Temperature True® Cryo Keeps Products Frozen at -150 to Meet Critical Demands of Healthcare Industry

UPS® (NYSE: UPS) today announced the launch of UPS Temperature True Cryo, which further broadens the scope of UPS temperature-sensitive shipping offerings to include cryogenic solutions for UPS healthcare customers.

The service includes real-time tracking and intervention services, which, when combined with UPS's proactive monitoring, risk mitigation solutions and global network of control towers, will provide complete visibility for cryogenic shipments at every stage of the supply chain journey.

The expansion is the latest addition to the UPS Temperature True suite of solutions. The innovative solution uses Cryoport's leading-edge cryogenic and related technologies, which allow UPS customers to use liquid nitrogen stored in dry vapor form to keep products frozen at -150 degrees C for 10 days while in transit or storage, providing a reliable, safe container for cryopreservation of products. It can also be paired with the industry first risk management, intervention and insurance solution, UPS Proactive Response Secure, to provide unprecedented coverage for time- and temperature-sensitive shipments.

"There is a growing spectrum of demand across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health, and we are excited to add UPS Temperature True Cryo to meet our clients' needs," said John Menna, UPS's vice president of global strategy for healthcare logistics. "The value and irreplaceable nature of products requiring cryopreservation highlight the need for a combination of cryogenic capability and financial risk mitigation - Temperature True Cryo and UPS Proactive Response Secure are a great pairing."

Product security, damage and spoilage are leading industry supply chain concerns as reported in the most recent UPS Pain in the (Supply) Chain Survey, a global study that measures healthcare logistics decision-makers' pain points. "We are committed to and will continue to diversify our portfolio to meet industry demands and offer our customers peace of mind by implementing the UPS quality standard they rely on as we integrate this solution into our portfolio," said Menna.

The UPS Temperature True portfolio offers temperature-sensitive storage and transportation solutions and services for products ranging from cryogenic to ambient, specifically tailored for companies in the pharmaceutical, biotech and medical device industries. UPS Temperature True Cryo follows the recent launch of three new Temperature True freight service levels that allow for different time-in-transit and control options for bulk temperature-sensitive shipments. These services are complemented by proactive monitoring and intervention technologies, extensive regulatory expertise and a global network of 46 UPS healthcare-dedicated facilities.

For more information on UPS's healthcare logistics solutions, visit:

About UPS

UPS (NYSE: UPS) is one of the world’s largest package delivery companies with 2019 revenue of $74 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. The company’s more than 500,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes a strong and unwavering stance in support of diversity, equality, and inclusion. The company can be found on the Internet at, with more information at and


For more information about this press release, contact: